Healthy high growth potential

Results

1470

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1470 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
543273
₹2,183.55-6.1%172.7%₹53.4b₹2,500.0067.753.9%n/aTransportation
VIKRAMSOLR
₹178.69-6.1%n/a₹64.7b₹246.6013.830.0%n/aSemiconductors
MONOLITH
₹764.852.5%139.8%₹16.6b₹960.0072.237.2%n/aMaterials
SAATVIKGL
₹450.20-7.7%n/a₹57.2b₹520.0016.048.8%n/aSemiconductors
SCHNEIDER
₹1,387.001.0%68.3%₹331.6b₹1,398.33156.034.0%n/aCapital Goods
501423
₹2,863.101.7%74.5%₹131.7b₹3,517.6777.533.7%0.1%Capital Goods
EIEL
₹221.720.6%-7.8%₹38.9b₹346.0021.337.8%n/aCapital Goods
APOLLO
₹418.856.0%119.8%₹157.5b₹382.50139.541.3%0.06%Capital Goods
MIDWESTLTD
₹1,261.80-2.4%n/a₹45.6b₹1,500.0043.559.3%n/aMaterials
CDR
zł224.50-0.7%-16.8%zł22.4bzł235.1343.429.7%0.4%Media
FWRY
ج.م18.40-3.2%50.8%ج.م62.7bج.م22.4523.627.3%n/aDiversified Financials
AXSM
US$240.661.2%131.6%US$12.6bUS$276.4717.557.4%n/aPharmaceuticals & Biotech
KEBNI B
SEK 1.07-12.4%-48.0%SEK 292.9mSEK 1.602.682.7%n/aTech
MDGL
US$514.390.9%71.4%US$12.4bUS$678.7110.559.2%n/aPharmaceuticals & Biotech
AGP
€7.02-1.5%-8.4%€128.0m€8.5725.837.8%n/aCapital Goods
2368
NT$1,230.00-0.8%324.1%NT$616.6bNT$1,485.0054.838.2%0.8%Tech
2455
NT$349.00-10.2%168.5%NT$66.3bNT$382.40110.245.2%0.8%Semiconductors
456A
JP¥1,402.00-8.4%n/aJP¥124.3bn/a39.723.4%n/aRetail
4417
JP¥4,055.0022.9%35.6%JP¥57.3bJP¥4,500.0041.024.1%0.8%Software
MOD
US$244.49-11.6%139.2%US$14.1bUS$340.86106.349.3%n/aCapital Goods
RHM
€1,050.6010.7%-39.3%€48.9b€1,765.6046.630.7%1.1%Capital Goods
CRDO
US$259.09-3.7%189.9%US$50.7bUS$269.81102.327.5%n/aSemiconductors
CORT
US$88.488.5%24.0%US$9.3bUS$88.00203.548.9%n/aPharmaceuticals & Biotech
NVDA
US$197.58-0.7%25.6%US$4.8tUS$301.6230.022.2%0.5%Semiconductors
Page 1 of 41